|
In response to released guidance for Requirements of Participation (RoP) Phase 3 and updates for Phase 2, the American Health Care Association (AHCA) is providing focused information to help skilled nursing facilities remain in compliance and avoid any failed practice. We give special thanks to the AHCA Survey and Regulatory staff for compiling and distributing this information. Elena Madrid, WHCA's Executive Vice President for Regulatory Affairs, co-chairs the AHCA Survey and Regulatory Committee and is a member of AHCA's Quality Cabinet.
The Centers for Medicare and Medicaid Services made changes to §483.80-Infection Control, and include the following:
-
F880-Infection Control. Facility must have an infection prevention and control program that includes explanations of standard and transmission-based precautions, droplet precautions, contact precautions, cleaning and disinfection and a water management program.
-
F881-Antibiotic Stewardship Program. Facility must monitor closely the antibiotics being prescribed to residents and provide feedback to prescribing practitioners.
-
F882-Infection Preventionist. Facility must have a specially trained infection preventionist working at least part time in the facility.
-
F883-Influenza and Pneumococcal Immunizations. Pneumococcal conjugate vaccine (PCV13) is no longer routinely recommended.
-
F868-QAA Committee. Infection Preventionist (IP) must be a member of the QAA committee and report to the committee on a regular basis.
AHCA members may also refer back to the following existing member resources:
Detailed information can be found in the Appendix PP-State Operations Manual. AHCA has also provided an expanded and full summary. If you have any questions, please email me or call me at (800) 562-6170, extension 105.
| 
